Search Editorial Photos
"needle injection"
243 professional editorial images found
#12489735
20 June 2025
The 'HIV' inscription displayed on a screen and illustrative syringes are seen in this illustration photo taken in Krakow, Poland on June 20, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12052966
14 February 2025
EDMONTON, CANADA - FEBRUARY 13: Medical syringes and influenza vaccine vials displayed in an illustrative composition in Edmonton, Alberta, Canada, on February 13, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12052967
14 February 2025
EDMONTON, CANADA - FEBRUARY 13: Medical syringes and influenza vaccine vials displayed in an illustrative composition in Edmonton, Alberta, Canada, on February 13, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12052968
14 February 2025
EDMONTON, CANADA - FEBRUARY 13: Medical syringes and influenza vaccine vials displayed in an illustrative composition in Edmonton, Alberta, Canada, on February 13, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12052969
14 February 2025
EDMONTON, CANADA - FEBRUARY 13: Medical syringes and influenza vaccine vials displayed in an illustrative composition in Edmonton, Alberta, Canada, on February 13, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12052965
14 February 2025
EDMONTON, CANADA - FEBRUARY 13: Medical syringes and influenza vaccine vials displayed in an illustrative composition in Edmonton, Alberta, Canada, on February 13, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798154
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798155
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798156
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798148
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798149
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798150
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798151
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798152
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798153
19 November 2023
Ozempic weight loss drug packaging is seen in this illustration photo with the Novo Nordisk logo in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10798142
19 November 2023
A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.